Immunoassay Analyzers Market Revenue Report

Immunoassay Analyzers Market Revenue Analysis By Product (Chemiluminescence, Immunofluorescence Analyzers, Radioimmunoassay, Elisa), By Application (Oncology, Infectious Disease Testing, Autoimmune Disease), And Segment Forecasts To 2024

Report ID: GVR-1-68038-992-0
Number of Pages: 85
Format: Electronic (PDF)

Historical Range: 2014 - 2015
Industry: Healthcare

Market segmentation

Global Immunoassay Instruments Product Outlook (Revenue, USD Million, 2014 - 2024)
- Chemiluminescence immunoassay
- Immunofluorescence analyzers
- Radioimmunoassay
- Enzyme-linked Immunoassay
- Consumables & Accessories
Global Immunoassay Instruments Application Outlook (Revenue, USD Million, 2014 - 2024)
- Therapeutic drug monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious disease testing
- Autoimmune disease
Immunoassay Instruments Regional Outlook (Revenue, USD Million, 2014 - 2024)
- North America
  - The U.S.
    - U.S. Product Outlook (Revenue, USD Million, 2014 - 2024)
      - Chemiluminescence immunoassay
      - Immunofluorescence analyzers
      - Radioimmunoassay
      - Enzyme-linked Immunoassay
      - Consumables & Accessories
    - U.S. Application Outlook (Revenue, USD Million, 2014 - 2024)
      - Therapeutic drug monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious disease testing
      - Autoimmune disease
  - Canada
    - Canada Product Outlook (Revenue, USD Million, 2014 - 2024)
      - Chemiluminescence immunoassay
      - Immunofluorescence analyzers
      - Radioimmunoassay
      - Enzyme-linked Immunoassay
      - Consumables & Accessories
    - Canada Application Outlook (Revenue, USD Million, 2014 - 2024)
      - Therapeutic drug monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious disease testing
      - Autoimmune disease
- Europe
  - UK
    - UK Product Outlook (Revenue, USD Million, 2014 - 2024)
      - Chemiluminescence immunoassay
      - Immunofluorescence analyzers
      - Radioimmunoassay
      - Enzyme-linked Immunoassay
      - Consumables & Accessories
    - UK Application Outlook (Revenue, USD Million, 2014- 2024)
      - Therapeutic drug monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious disease testing
      - Autoimmune disease
  - Germany
    - Germany Product Outlook (Revenue, USD Million, 2014 - 2024)
      - Chemiluminescence immunoassay
      - Immunofluorescence analyzers
      - Radioimmunoassay
      - Enzyme-linked Immunoassay
      - Consumables & Accessories
    - Germany Application Outlook (Revenue, USD Million, 2014 - 2024)
      - Therapeutic drug monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious disease testing
      - Autoimmune disease
- Asia Pacific
  - Japan
    - Japan Product Outlook (Revenue, USD Million, 2014 - 2024)
      - Chemiluminescence immunoassay
      - Immunofluorescence analyzers
      - Radioimmunoassay
      - Enzyme-linked Immunoassay
      - Consumables & Accessories
    - Japan Application Outlook (Revenue, USD Million, 2014 - 2024)
      - Therapeutic drug monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious disease testing
      - Autoimmune disease
  - China
    - China Product Outlook (Revenue, USD Million, 2014 - 2024)
      - Chemiluminescence immunoassay
      - Immunofluorescence analyzers
      - Radioimmunoassay
      - Enzyme-linked Immunoassay
      - Consumables & Accessories
    - China Application Outlook (Revenue, USD Million, 2014 - 2024)
      - Therapeutic drug monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious disease testing
      - Autoimmune disease
- Latin America
  - Brazil
    - Brazil Product Outlook (Revenue, USD Million, 2014 - 2024)
      - Chemiluminescence immunoassay
      - Immunofluorescence analyzers
      - Radioimmunoassay
      - Enzyme-linked Immunoassay
      - Consumables & Accessories
    - Brazil Application Outlook (Revenue, USD Million, 2014 - 2024)
      - Therapeutic drug monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious disease testing
      - Autoimmune disease
  - Mexico
    - Mexico Product Outlook (Revenue, USD Million, 2014 - 2024)
      - Chemiluminescence immunoassay
      - Immunofluorescence analyzers
      - Radioimmunoassay
      - Enzyme-linked Immunoassay
      - Consumables & Accessories
    - Mexico Application Outlook (Revenue, USD Million, 2014 - 2024)
      - Therapeutic drug monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious disease testing
      - Autoimmune disease
- MEA
  - South Africa
    - South Africa Product Outlook (Revenue, USD Million, 2014 - 2024)
      - Chemiluminescence immunoassay
      - Immunofluorescence analyzers
      - Radioimmunoassay
      - Enzyme-linked Immunoassay
      - Consumables & Accessories
    - South Africa Application Outlook (Revenue, USD Million, 2014 - 2024)
      - Therapeutic drug monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious disease testing
      - Autoimmune disease

Report Content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2014 to 2024
Revenue estimates for technology up to 2024
Revenue estimates for type up to 2024
Revenue estimates for application up to 2024
Regional market size and forecast for product up to 2024

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.